Senti Biosciences Analyst Ratings
Senti Biosciences Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/15/2023 | 663.36% | Chardan Capital | → $6 | Reiterates | Buy → Buy |
| 05/11/2023 | 663.36% | Chardan Capital | $7 → $6 | Maintains | Buy |
| 03/24/2023 | 154.45% | Morgan Stanley | $3 → $2 | Maintains | Equal-Weight |
| 03/23/2023 | 790.59% | Chardan Capital | $8 → $7 | Maintains | Buy |
| 01/30/2023 | 917.81% | Chardan Capital | $12 → $8 | Maintains | Buy |
| 01/27/2023 | 281.68% | Morgan Stanley | $7.5 → $3 | Maintains | Equal-Weight |
| 12/16/2022 | — | JP Morgan | Initiates Coverage On | → Neutral | |
| 10/07/2022 | 854.2% | Morgan Stanley | → $7.5 | Initiates Coverage On | → Equal-Weight |
| 09/29/2022 | 790.59% | B of A Securities | → $7 | Initiates Coverage On | → Buy |
| 09/23/2022 | 1426.72% | Chardan Capital | → $12 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月15日 | 663.36% | 查爾丹資本 | →$6 | 重申 | 購買→購買 |
| 2023年05月11日 | 663.36% | 查爾丹資本 | $7→$6 | 維護 | 買 |
| 03/24/2023 | 154.45% | 摩根士丹利 | $3→$2 | 維護 | 等重 |
| 03/23/2023 | 790.59% | 查爾丹資本 | $8→$7 | 維護 | 買 |
| 2023年1月30日 | 917.81% | 查爾丹資本 | $12→$8 | 維護 | 買 |
| 2023年1月27日 | 281.68% | 摩根士丹利 | $7.5→$3 | 維護 | 等重 |
| 12/16/2022 | - | 摩根大通 | 開始承保 | →中性 | |
| 10/07/2022 | 854.2% | 摩根士丹利 | →$7.5 | 開始承保 | →等重 |
| 09/29/2022 | 790.59% | B of A證券 | →$7 | 開始承保 | →購買 |
| 09/23/2022 | 1426.72% | 查爾丹資本 | →$12 | 開始承保 | →購買 |
What is the target price for Senti Biosciences (SNTI)?
森蒂生物科學公司(SNTI)的目標價格是多少？
The latest price target for Senti Biosciences (NASDAQ: SNTI) was reported by Chardan Capital on August 15, 2023. The analyst firm set a price target for $6.00 expecting SNTI to rise to within 12 months (a possible 663.36% upside). 10 analyst firms have reported ratings in the last year.
查爾丹資本於2023年8月15日報道了森蒂生物科學公司(納斯達克：SNTI)的最新目標價。這家分析公司將目標價定為6美元，預計SNTI將在12個月內升至(可能上漲663.36%)。去年有10家分析公司公佈了評級。
What is the most recent analyst rating for Senti Biosciences (SNTI)?
Senti Biosciences(SNTI)的最新分析師評級是多少？
The latest analyst rating for Senti Biosciences (NASDAQ: SNTI) was provided by Chardan Capital, and Senti Biosciences reiterated their buy rating.
納斯達克(股票代碼：SNTI)的最新分析師評級由查爾丹資本提供，森蒂生物科學重申其買入評級。
When is the next analyst rating going to be posted or updated for Senti Biosciences (SNTI)?
Senti Biosciences(SNTI)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Senti Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Senti Biosciences was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Senti Biosciences的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Senti Bioscience的上一次評級是在2023年8月15日提交的，所以你應該預計下一次評級將在2024年8月15日左右的某個時候提供。
Is the Analyst Rating Senti Biosciences (SNTI) correct?
分析師對Senti Biosciences(SNTI)的評級正確嗎？
While ratings are subjective and will change, the latest Senti Biosciences (SNTI) rating was a reiterated with a price target of $0.00 to $6.00. The current price Senti Biosciences (SNTI) is trading at is $0.79, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的森蒂生物科學(SNTI)評級被重申，目標價在0.00美元至6.00美元之間。Senti Biosciences(SNTI)目前的交易價格為0.79美元，在分析師的預測範圍內。